Initial Management of Thyroid Goiter
Begin with thyroid function tests (TSH) followed immediately by thyroid ultrasound—these two tests form the essential foundation for all subsequent management decisions. 1, 2
Diagnostic Algorithm
Step 1: Thyroid Function Testing
- Measure TSH first as it is the most sensitive initial test (98% sensitivity, 92% specificity) and will guide your entire imaging pathway 2
- Add free T4 and free T3 to evaluate the functional status of the thyroid 2
- The TSH result determines whether additional nuclear imaging is needed or contraindicated 1
Step 2: Thyroid Ultrasound (Perform in ALL Cases)
- Ultrasound is the mandatory first-line imaging modality regardless of TSH level 1, 2
- It confirms the mass originates from thyroid tissue 2
- It characterizes goiter size, morphology, and identifies nodules 2
- It stratifies malignancy risk using ACR TI-RADS criteria for any nodules present 2
- Critical pitfall to avoid: Never skip ultrasound and proceed directly to nuclear imaging, as you will miss coexisting thyroid nodules requiring biopsy for malignancy evaluation 1
Step 3: TSH-Guided Additional Testing
If TSH is LOW (thyrotoxicosis):
- Proceed to radioiodine uptake scan after ultrasound 1
- This differentiates Graves' disease, toxic adenoma, toxic multinodular goiter, and thyroiditis 1
- The scan also helps plan radioactive iodine therapy if needed 1
If TSH is NORMAL (euthyroid):
- Do NOT order radionuclide scanning—it wastes resources and has low diagnostic value in euthyroid patients 1, 2
- Radionuclide scanning has low positive predictive value for malignancy and does not help decide which nodules to biopsy 1, 2
- Use ultrasound findings alone to guide fine-needle aspiration biopsy decisions based on ACR TI-RADS criteria 2
If TSH is HIGH (hypothyroidism):
- Imaging is generally not indicated 1
- If imaging is needed for other reasons, ultrasound is appropriate but does not differentiate causes of hypothyroidism 1
Step 4: Evaluate for Compressive Symptoms
If patient has dyspnea, orthopnea, dysphagia, or dysphonia:
- Add CT scan of neck and chest to evaluate substernal extension and tracheal compression 3, 2, 4
- CT is superior to ultrasound for evaluating substernal extension and defining the degree of tracheal compression 3, 2
- CT has less respiratory motion artifact than MRI 3
- Surgical referral is indicated for goiters causing compressive symptoms 4
Specific compressive findings requiring CT:
- Retrosternal extension into the mediastinum can cause significant tracheal compression 3
- Symptoms include progressive dyspnea (especially when lying flat), obstructive sleep apnea, and stridor 3
- Choking and dyspnea are the most common presenting symptoms of retrosternal goiter 5
Management Based on Findings
For Nodular Goiter:
- Use ACR TI-RADS criteria from ultrasound to select nodules for fine-needle aspiration biopsy 2
- Biopsy should only occur after ultrasound characterization, not as an initial diagnostic study 2
- The malignancy rate in retrosternal goiters is approximately 12% 5
For Symptomatic/Compressive Goiter:
- Surgical thyroidectomy is the treatment of choice for goiters with compressive symptoms 4, 5
- Most patients (91%) can be approached through a cervical incision 5
- Median sternotomy is required in approximately 9% of cases 5
- Studies demonstrate improved breathing and swallowing outcomes after thyroidectomy 4
For Toxic Goiter (Low TSH):
- Treatment options include radioactive iodine therapy, which has 98% success rate for hot nodules 1
- Radioiodine therapy causes mean 32% nodule volume reduction at 6 months 1
- Surgery is also an option for toxic multinodular goiter 6
Common Pitfalls to Avoid
- Never proceed directly to uptake scan without checking TSH and performing ultrasound first 1
- Never use radionuclide scanning to determine malignancy in euthyroid patients 1, 2
- Never skip ultrasound evaluation—structural abnormalities like substernal extension or suspicious nodules will be missed 1
- Never order PET/CT with FDG for initial goiter evaluation—it has no role 2